Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for NIR Method Development for In-Process Testing – V 2.0

Posted on By

Analytical Method Development: SOP for NIR Method Development for In-Process Testing – V 2.0

Standard Operating Procedure for NIR Method Development in In-Process Testing


Department Analytical Method Development
SOP No. SOP/AMD/178/2025
Supersedes SOP/AMD/178/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP defines the procedure for developing and validating Near Infrared (NIR) spectroscopy methods used for in-process testing (IPT) of pharmaceutical materials, focusing on real-time,

non-destructive analysis of blend uniformity, moisture content, and identity verification.

2. Scope

This SOP is applicable to the Analytical Method Development (AMD) and manufacturing support teams responsible for deploying NIR-based tools for monitoring critical quality attributes (CQAs) during blending, granulation, drying, and tablet compression stages.

3. Responsibilities

  • Analytical Scientist: Designs and validates NIR methods, prepares calibration models, and interprets results.
  • Instrument Analyst: Operates NIR spectrometer, ensures calibration and maintenance, and captures IPT data.
  • QA Officer: Reviews validation data and monitors GMP adherence.
  • Head – AMD: Approves final method and ensures alignment with regulatory expectations.
See also  Analytical Method Development: SOP for HPTLC Method Development - V 2.0

4. Accountability

The Head of AMD is accountable for ensuring NIR methods are validated, compliant with ICH and PAT guidelines, and effective for real-time process monitoring.

5. Procedure

5.1 Instrument Calibration and Setup

  1. Calibrate wavelength accuracy using certified reference materials (e.g., polystyrene or SRM standards).
  2. Verify photometric response, noise, and resolution specifications per instrument manufacturer instructions.
  3. Record all calibration results in Annexure-1: NIR Calibration Log.

5.2 Sample Preparation

  1. Use representative samples from various stages (pre-blend, post-blend, granules, tablets).
  2. No dilution or sample treatment is required; ensure uniform surface for consistent spectra.
  3. Use sample cup, glass vials, or inline probes as per instrument configuration.

5.3 Method Development Parameters

  1. Wavelength Range: 800–2500 nm (or instrument-specific range).
  2. Resolution: ≤ 10 nm spectral resolution.
  3. Scans per Spectrum: 32–64 scans to reduce noise.
  4. Integration Time: Adjust based on signal-to-noise ratio and sample reflectance.
  5. Collect reference spectra from authentic samples with known properties.

5.4 Calibration Model Building

  1. Use chemometric software (e.g., Unscrambler, SIMCA) to build calibration models.
  2. Apply multivariate methods such as PLS (Partial Least Squares) or PCA (Principal Component Analysis).
  3. Include minimum 20–30 representative samples spanning expected concentration ranges.
  4. Validate model by comparing predicted vs. actual values (R² ≥ 0.98, RMSEC ≤ 5%).
  5. Save and secure calibration model; document in Annexure-2: Model Development Sheet.
See also  Analytical Method Development: SOP for Identification of Preservatives in Multi-Dose Vials - V 2.0

5.5 Method Validation

  1. Validate per ICH Q2(R2) and EMA PAT guidelines:
    • Specificity: Differentiate between active and excipient spectra.
    • Linearity: R² ≥ 0.98 across working range.
    • Accuracy: Recovery within 95%–105% against reference method.
    • Precision: RSD ≤ 3% for repeat measurements.
    • Robustness: Assess under varying environmental/light conditions.
  2. Summarize in Annexure-3: NIR Validation Summary.

5.6 Application in In-Process Testing

  1. Use NIR for:
    • Real-time monitoring of blend uniformity.
    • Moisture tracking during fluid bed drying.
    • Content uniformity during compression or coating.
    • Rapid ID testing of incoming materials at warehouse.
  2. Integrate with control systems for automatic release or rejection.
  3. Maintain results and logs in Annexure-4: In-Process NIR Test Record.

6. Abbreviations

  • NIR: Near Infrared Spectroscopy
  • PAT: Process Analytical Technology
  • RSD: Relative Standard Deviation
  • PLS: Partial Least Squares
  • PCA: Principal Component Analysis
  • SOP: Standard Operating Procedure

7. Documents

  1. NIR Calibration Log – Annexure-1
  2. Model Development Sheet – Annexure-2
  3. NIR Validation Summary – Annexure-3
  4. In-Process NIR Test Record – Annexure-4
See also  Analytical Method Development: SOP for Analytical Method for Liposomes - V 2.0

8. References

  • ICH Q2(R2) – Validation of Analytical Procedures
  • FDA Guidance for PAT – A Framework for Innovative Pharmaceutical Development
  • USP <856> – NIR Spectroscopy
  • EMA QbD and PAT Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: NIR Calibration Log

Date Standard Used Wavelength Accuracy (nm) Status Analyst
18/05/2025 Polystyrene Film +0.6 nm @ 1900 nm Pass Rajesh Kumar

Annexure-2: Model Development Sheet

Model ID Application Sample Size R² RMSEC Status
NIR-BLEND-23 Blend Uniformity 30 0.989 4.1% Valid

Annexure-3: NIR Validation Summary

Parameter Result Criteria Status
Precision RSD = 2.1% ≤ 3% Pass
Accuracy 97.2% 95%–105% Pass

Annexure-4: In-Process NIR Test Record

Batch No. Stage Result Acceptance Limit Status
BLND/2025/117 Post-blend 98.6% 95%–105% Complies

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Included PAT applications and inline validation steps Annual SOP Review
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Conducting Mock Recalls of Injectable Products – V 2.0
Next Post: Biosimilars: SOP for Material Traceability in Upstream – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version